Spatial awareness in parasite immuno-epidemiology

Parasite Immunology

Volumn 26, Issue 11-12, 2004, Pages 499-507

  Booth, Mark ^a   Dunne, David W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BEHAVIOR; DEMOGRAPHY; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; GENETIC ANALYSIS; HOST PARASITE INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOEPIDEMIOLOGY; IMMUNOLOGY; NONHUMAN; PARASITE; PARASITE IMMUNITY; PARASITOSIS; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA MANSONI; SEROLOGY; SPATIAL ORIENTATION; SUPERINFECTION;

ANIMALS; ANTIGENS, PROTOZOAN; GEOGRAPHIC INFORMATION SYSTEMS; HOST-PARASITE RELATIONS; HUMANS; MALARIA, FALCIPARUM; PARASITE EGG COUNT; PARASITES; PARASITIC DISEASES; PLASMODIUM FALCIPARUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI;

EID: 16244367749     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00735.x     Document Type: Review

References (75)

1. Brooker S & Michael E. The potential of geographical information systems and remote sensing in the epidemiology and control of human helminth infections. Adv Parasitol 2000; 47: 245-88.
2. van Dam GJ, Stelma FF, Gryseels B et al. Antibody response patterns against Schistosoma mansoni in a recently exposed community in Senegal. J Infect Dis 1996; 173: 1232-41.
3. Webster M, Libranda-Ramirez BD, Aligui GD et al. The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines. Parasitology 1997; 114: 383-93.
4. Naus CW, Booth M, Jones FM et al. The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community. Trop Med Int Health 2003; 8: 561-68.
5. Sack U, Burkhardt U, Borte M, Schadlich H, Berg K & Emmrich F. Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol 1998; 5: 28-32.
6. Tsaknaridis L, Spencer L, Culbertson N et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003; 74: 296-308.
7. Xainli J, Baisor M, Kastens W, Bockarie M, Adams JH & King CL. Age-dependent cellular immune responses to Plasmodium vivax Duffy binding protein in humans. J Immunol 2002; 169: 3200-7.
8. Bongartz M, Rezbach P, Borrmann S, Hollingdale MR, Kremsner PG & Luty AJ. Age-dependent enhancement of IFN-gamma responses to Plasmodium falciparum liver stage antigen-1 T cell epitopes. Parasitol Res 2002; 88: 1083-89.
9. Roberts M, Butterworth AE, Kimani G et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 1993; 61: 4984-93.
10. MacDonald AJ, Turaga PS, Harmon-Brown C et al. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. Infect Immun 2002; 70: 2796-804.
11. Booth M, Mwatha JK, Joseph S et al. Peri-portal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFNγ, high TNFα or low RANTES, depending on age and gender. J Immunol 2004; 172: 1295-303.
12. Naus CW, Kimani G, Ouma JH et al. Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age. Infect Immun 1999; 67: 3444-51.
13. Booth M, Vennervald BJ, Kadzo H et al. Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence. Trans R Soc Trop Med Hyg 2004; 98: 125-36.
14. Bethony J, Williams JT, Kloos H et al. Exposure to Schistosoma mansoni infection in a rural area in Brazil. II: household risk factors. Trop Med Int Health 2001; 6: 136-45.
15. Stirnadel HA, Beck HP, Alpers MP & Smith TA. Genetic analysis of IgG subclass responses against RESA and MSP2 of Plasmodium falciparum in adults in Papua New Guinea. Epidemiol Infect 2000; 124: 153-62.
16. Aucan C, Walley AJ, Hennig BJ et al. Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun 2003; 4: 275-82.
17. Cooke GS, Aucan C, Walley AJ et al. Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg 2003; 69: 565-8.
18. Bethony J, Silveira AM, Alves-Oliveira LF et al. Familial resemblance in humoral immune response to defined and crude Schistosoma mansoni antigens in an endemic area in Brazil. J Infect Dis 1999; 180: 1665-73.
19. Henri S, Chevillard C, Mergani A et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 2002; 169: 929-36.
20. Rodrigues V Jr, Abel L, Piper K & Dessein AJ. Segregation analysis indicates a major gene in the control of interleukine-5 production in humans infected with Schistosoma mansoni. Am J Hum Genet 1996; 59: 453-61.
21. Brooker S, Singhasivanon P, Waikagul J et al. Mapping soil-transmitted helminths in Southeast Asia and implications for parasite control. Southeast Asian J Trop Med Public Health 2003; 34: 24-36.
22. Mabaso ML, Appleton CC, Hughes JC & Gouws E. The effect of soil type and climate on hookworm (Necator americanus) distribution KwaZulu-Natal, South Africa. Trop Med Int Health 2003; 8: 722-7.
23. Appleton CC & Gouws E. The distribution of common intestinal nematodes along an altitudinal transect in KwaZulu-Natal, South Africa. Ann Trop Med Parasitol 1996; 90: 181-8.
24. Kariuki HC, Clennon JA, Brady MS et al. Distribution patterns and cercarial shedding of Bulinus nasutus and other snails in the Msambweni area, Coast Province, Kenya. Am J Trop Med Hyg 2004; 70: 449-56.
25. Fulford AJ, Ouma JH, Kariuki HC et al. Water contact observations in Kenyan communities endemic for schistosomiasis: methodology and patterns of behaviour. Parasitology 1996; 113: 223-41.
26. Balls MJ, Bodker R, Thomas CJ, Kisinza W, Msangeni HA & Lindsay SW. Effect of topography on the risk of malaria infection in the Usambara Mountains, Tanzania. Trans R Soc Trop Med Hyg 2004; 98: 400-8.
27. Brooker S, Clarke S, Njagi JK et al. Spatial clustering of malaria and associated risk factors during an epidemic in a highland area of western Kenya. Trop Med Int Health 2004; 9: 757-66.
28. Bogh C, Clarke SE, Jawara M, Thomas CJ & Lindsay SW. Localized breeding of the Anopheles gambiae complex (Diptera: Culicidae) along the River Gambia, West Africa. Bull Entomol Res 2003; 93: 279-87.
29. Booth M, Vennervald BJ, Kenty LC et al. Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BMC Infectious Dis 2004; 4: 13.
30. Clennon JA, King CH, Muchiri EM et al. Spatial patterns of urinary schistosomiasis infection in a highly endemic area of coastal Kenya. Am J Trop Med Hyg 2004; 70: 443-8.
31. Thompson R, Begtrup K, Cuamba N et al. The Matola malaria project: a temporal and spatial study of malaria transmission and disease in a suburban area of Maputo, Mozambique. Am J Trop Med Hyg 1997; 57: 550-9.
32. Clarke SE, Bogh C, Brown RC, Walraven GE, Thomas CJ & Lindsay SW. Risk of malaria attacks in Gambian children is greater away from malaria vector breeding sites. Trans R Soc Trop Med Hyg 2002; 96: 499-506.
33. Muller I, Smith T, Mellor S, Rare L & Genton B. The effect of distance from home on attendance at a small rural health centre in Papua New Guinea. Int J Epidemiol 1998; 27: 878-84.
34. Schellenberg JA, Newell JN, Snow RW et al. An analysis of the geographical distribution of severe malaria in children in Kilifi District, Kenya. Int J Epidemiol 1998; 27: 323-9.
35. Kullberg MC, Pearce EJ, Hieny SE, Sher A & Berzofsky JA. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J Immunol 1992; 148: 3264-70.
36. Liesenfeld O, Dunay IR & Erb KJ. Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus brasiliensis infection. Infect Immun 2004; 72: 3812-22.
37. La Flamme AC, Scott P & Pearce EJ. Schistosomiasis delays lesion resolution during Leishmania major infection by impairing parasite killing by macrophages. Parasite Immunol 2002; 24: 339-45.
38. Brady MT, O'Neill SM, Dalton JP & Mills KH. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun 1999; 67: 5372-8.
39. Rodriguez M, Terrazas LI, Marquez R & Bojalil R. Susceptibility to Trypanosoma cruzi is modified by a previous non-related infection. Parasite Immunol 1999; 21: 177-85.
40. Curry AJ, Else KJ, Jones F, Bancroft A, Grencis RK & Dunne DW. Evidence that cytokine-mediated immune interactions induced by Schistosoma mansoni alter disease outcome in mice concurrently infected with Trichuris muris. J Exp Med 1995; 181: 769-74.
41. Marshall AJ, Brunet LR, van Gessel Y et al. Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice. J Immunol 1999; 163: 2089-97.
42. Sher A, Pearce E & Kaye P Shaping the immune response to parasites: role of dendritic cells. Curr Opin Immunol 2003; 15: 421-9.
43. McKee AS & Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 1224-31.
44. Maizels RM & Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3: 733-44.
45. Sabin EA, Araujo MI, Carvalho EM & Pearce EJ. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis 1996; 173: 269-72.
46. Malhotra I, Mungai P, Wamachi A et al. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and Schistosomiasis. J Immunol 1999; 162: 6843-8.
47. Porto AF, Neva FA, Bittencourt H et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001; 23: 503-7.
48. Porto AF, Santos SB, Alcantara L et al. HTLV-1 modifies the clinical and immunological response to Schistosomiasis. Clin Exp Immunol 2004; 137: 424-9.
49. Doenhoff MJ, Chiodini PL & Hamilton JV. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies? Trends Parasitol 2004; 20: 35-9.
50. Engels D, Sinzinkayo E, De Vlas SJ & Gryseels B. Intraspecimen fecal egg count variation in Schistosoma mansoni infection. Am J Trop Med Hyg 1997; 57: 571-7.
51. Utzinger J, Booth M, N'Goran EK, Muller I, Tanner M & Lengeler C. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 2001; 122: 537-44.
52. Charlwood JD, Smith T, Lyimo E et al. Incidence of Plasmodium falciparum infection in infants in relation to exposure to sporozoite-infected anophelines. Am J Trop Med Hyg 1998; 59: 243-51.
53. Smith T, Charlwood JD, Takken W, Tanner M & Spiegelhalter DJ. Mapping the densities of malaria vectors within a single village. Acta Trop 1995; 59: 1-18.
54. Mbogo CM, Mwangangi JM, Nzovu J et al. Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg 2003; 68: 734-42.
55. Nacher M. Worms and malaria: noisy nuisances and silent benefits. Parasite Immunol 2002; 24: 391-93.
56. Nacher M, Gay F, Singhasivanon P et al. Ascaris lumbricoides infection is associated with protection from cerebral malaria. Parasite Immunol 2000; 22: 107-13.
57. Nacher M, Treeprasertsuk S, Singhasivanon P et al. Association of intestinal helminths with decreased liver size and sCD23 concentration during falciparum malaria. Southeast Asian J Trop Med Public Health 2004; 35: 31-4.
58. Raso G, Luginbuhl A, Adjoua CA et al. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Cote d'Ivoire. Int J Epidemiol 2004; 33: 1092-102.
59. Booth M, Vounatsou P, N'Goran EK, Tanner M & Utzinger J. The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Cote d'Ivoire. Parasitology 2003; 127: 525-31.
60. Von Steiger B, Webster R, Schulin R & Lehmann R. Mapping heavy metals in polluted soil by disjunctive kriging. Environ Pollut 1996; 94: 205-15.
61. Tayanc M. An assessment of spatial and temporal variation of sulfur dioxide levels over Istanbul, Turkey. Environ Pollut 2000; 107: 61-9.
62. Pleydell DR, Raoul F, Tourneux F et al. Modelling the spatial distribution of Echinococcus multilocularis infection in foxes. Acta Trop 2004; 91: 253-65.
63. Fortes Bde P, Ortiz Valencia LI, Ribeiro Sdo V & Medronho Rde A. [Geostatistical modelling of Ascaris lumbricoides infection]. Cad Saude Publica 2004; 20: 727-34.
64. Kleinschmidt I, Sharp BL, Clarke GP, Curtis B & Fraser C. Use of generalized linear mixed models in the spatial analysis of small-area malaria incidence rates in Kwazulu Natal, South Africa. Am J Epidemiol 2001; 153: 1213-21.
65. Ribeiro JM, Seulu F, Abose T, Kidane G & Teklehaimanot A. Temporal and spatial distribution of anopheline mosquitos in an Ethiopian village: implications for malaria control strategies. Bull World Health Organ 1996; 74: 299-305.
66. Wakefield JC, et al. In: Spatial Epidemiology: Methods and Applications, eds Elliott P, Wakefield JC, Best N & Briggs D. New York: Oxford University Press; 2000: 128-152.
67. Kulldorff M & Nagarwalla N. Spatial disease clusters: detection and inference. Stat Med 1995; 14: 799-810.
68. Odoi A, Martin SW, Michel P, Holt J, Middleton D & Wilson J. Geographical and temporal distribution of human giardiasis in Ontario. Can Int J Health Geogr 2003; 2: 5.
69. Cressie N. Statistics for Spatial Data, revised edn. New York: John Wiley and Sons; 1993.
70. Waller LA & Gotway CA. Applied Spatial Statistics for Public Health Data. Hoboken NJ: John Wiley & Sons, Inc; 2004.
71. Soboslay PT, Dreweck CM, Hoffmann WH et al. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin Exp Immunol 1992; 89: 407-13.
72. Fitzsimmons CM, Joseph S, Jones FM et al. Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E. Infect Immun 2004; 72: 4023-30.
73. Joseph S, Jones FM, Walter K et al. Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel. J Infect Dis 2004; 190: 835-42.
74. Vennervald BJ, Kenty LC, Butterworth AE et al. Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis. Trop Med Int Health 2004; 9: 461-70.
75. Booth M, Vennervald BJ, Butterworth AE et al. Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children. BMC Med 2004; 2: 36.